|Articles|June 4, 2015

Merge eClinical Announces New Mobile App

Author(s)Applied Clinical Trials Editorial Staff

Study Connect™ App Enables the Mobile Management of Randomization, Inventory Management and Unblinding in Clinical Trials

Study Connect™, a new mobile app from Merge eClinical, allow users of its eClinicalOS (eCOS) to perform a wide array of clinical trial management functions from their iOS-based mobile devices.

Seamlessly integrated with eCOS, Study Connect™enables researchers to:

· Manage randomization of subjects

· Coordinate dispensing and inventory management

· Unblind individual subjects, as circumstances warrant

· Stay connected with real-time customized notifications

· Monitor enrollment and establish milestone alerts

· Share top-level statistics for each study with key stakeholders using the study dashboard

· Expedite approval response times for critical study decisions such as patient study eligibility

· Maintain security with the ability to set customized role-based permissions for individual studies.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Merge eClinical Announces New Mobile App

Newsletter

Related Articles